UnfairGaps
🇦🇺Australia

TGA Non-Compliance Penalties

2 verified sources

Definition

Clinical trial design and patient recruitment must comply with TGA regulations requiring notification and HREC ethics approval. Non-compliance or delays result in enforceable undertakings, fines, or trial halts, creating financial losses from rework and lost timelines.

Key Findings

  • Financial Impact: AUD 50,000 - 500,000 per violation (civil penalties up to 5,000 penalty units at AUD 313/unit); 20-40% trial budget overrun from delays.
  • Frequency: Per non-compliant trial; high risk in recruitment ethics breaches.
  • Root Cause: Manual handling of complex ethics submissions and patient consent processes prone to errors.

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Biotechnology Research.

Affected Stakeholders

Clinical Operations Manager, Regulatory Affairs Specialist, Trial Sponsor

Action Plan

Run AI-powered research on this problem. Each action generates a detailed report with sources.

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Related Business Risks